HYALUAMIN®
INTENDED USE
Who it's for
WHO IS HYALUAMIN STRONG INDICATED FOR?
-
Patients with mild to moderate knee osteoarthritis
-
Adults aged 45/50 and over who wish to preserve joint mobility
-
Adult and older athletes exposed to repeated joint microtrauma
-
Individuals seeking to delay surgical interventions by opting for advanced orthobiological technologies
-
Those looking for an innovative and superior alternative to traditional viscosupplementation
THE VICIOUS CIRCLE OF OSTEOARTHRITIS
1
GONALGIA
2
RELEASE OF INFLAMMATORY MEDIATORS
3
HYPOTROPHY
4
MECHANICAL STRESS INCREASED
5
DEGRADATION
6
REDUCED MOBILITY
TARGET POPULATION
HYALUAMIN® Strong is indicated for:
Mild to moderate knee osteoarthritis (Kellgren-Lawrence I–III)
Adults ≥45 years with persistent joint pain
Reduced mobility and compromised daily activities
Mature athletes exposed to repetitive joint trauma
Candiates to defer surgical intervention
Patients seeking alternatives to NSAIDs/corticosteroids
Osteoarthritis
Pain reduction is a key component of the therapeutic approach
Osteoarthritis affects approximately 528 million people worldwide, representing 23% of the global population aged ≥40 years. (*)
The most commonly affected joint in osteoarthritis is the knee, accounting for approximately 60–85% of all OA cases. (*)
OA-related pain represents a major barrier to maintaining physical activity and is one of the leading causes of disability. (*)
​
* Langworthy M, Dasa V, Spitzer AI. Knee osteoarthritis: disease burden, available treatments, and emerging options.
Ther Adv Musculoskelet Dis 2024;16:1759720X241273009.